Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Time for Qs to be asked about the GSA Press Release ..

<Was the GSA contract subject to some lag period for final confirmation that just ended in April, or was the March grant date the final approval?>

Darn good question. Wish I knew. But that brings up yet another question. I see that Crossflo is not listed in the GSA's Advantage Catalogue. I think that means that Crossflo is not selling anything directly. Hence, it is not just the Crossflo software that was approved, but perhaps a comprehensive offering through one of our partners. And if that is the case, perhaps the information did not flow directly to Crossflo, but through the partner. Doesn't anyone here know how these things work? Opty

Share
New Message
Please login to post a reply